Susquehanna International Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $851K | Buy |
41,505
+1,804
| +5% | +$37K | ﹤0.01% | 3522 |
|
|
2025
Q1 | $813K | Sell |
39,701
-56,664
| -59% | -$1.16M | ﹤0.01% | 3658 |
|
|
2024
Q4 | $2.18M | Buy |
96,365
+62,797
| +187% | +$1.42M | ﹤0.01% | 1856 |
|
|
2024
Q3 | $826K | Buy |
33,568
+12,038
| +56% | +$296K | ﹤0.01% | 2945 |
|
|
2024
Q2 | $498K | Buy |
+21,530
| New | +$498K | ﹤0.01% | 3527 |
|
|
2024
Q1 | – | Sell |
-25,752
| Closed | -$593K | – | 6021 |
|
|
2023
Q4 | $593K | Sell |
25,752
-65,467
| -72% | -$1.51M | ﹤0.01% | 3605 |
|
|
2023
Q3 | $1.86M | Buy |
91,219
+15,432
| +20% | +$314K | ﹤0.01% | 1906 |
|
|
2023
Q2 | $1.77M | Buy |
75,787
+25,133
| +50% | +$587K | ﹤0.01% | 2038 |
|
|
2023
Q1 | $1.18M | Buy |
50,654
+30,815
| +155% | +$717K | ﹤0.01% | 2658 |
|
|
2022
Q4 | $499K | Buy |
+19,839
| New | +$499K | ﹤0.01% | 3226 |
|
|
2022
Q3 | – | Sell |
-62,142
| Closed | -$1.8M | – | 6485 |
|
|
2022
Q2 | $1.8M | Buy |
+62,142
| New | +$1.8M | ﹤0.01% | 1778 |
|
|
2021
Q1 | – | Sell |
-26,757
| Closed | -$1.23M | – | 5430 |
|
|
2020
Q4 | $1.23M | Sell |
26,757
-411
| -2% | -$18.9K | ﹤0.01% | 2314 |
|
|
2020
Q3 | $1.06M | Buy |
+27,168
| New | +$1.06M | ﹤0.01% | 2139 |
|